If a variant has more than one submission, it may be counted in more than one significance column. If this is the case, the total number of variants will be less than the sum of the other cells.
pathogenic | likely pathogenic | uncertain significance | likely benign | benign | total |
---|---|---|---|---|---|
35 | 39 | 19 | 1 | 4 | 98 |
Gene and significance breakdown #
Gene or gene combination | pathogenic | likely pathogenic | uncertain significance | likely benign | benign | total |
---|---|---|---|---|---|---|
HARS1 | 4 | 0 | 1 | 0 | 0 | 5 |
WFS1 | 0 | 3 | 2 | 0 | 0 | 5 |
COQ4 | 4 | 0 | 0 | 0 | 0 | 4 |
PNPLA6 | 2 | 2 | 0 | 0 | 0 | 4 |
HPDL | 3 | 0 | 0 | 0 | 0 | 3 |
LYST | 0 | 1 | 2 | 0 | 0 | 3 |
SACS | 0 | 0 | 3 | 0 | 0 | 3 |
SETX | 0 | 2 | 1 | 0 | 0 | 3 |
SPG7 | 2 | 0 | 1 | 0 | 0 | 3 |
STXBP1 | 2 | 1 | 0 | 0 | 0 | 3 |
AFG3L2 | 0 | 2 | 0 | 0 | 0 | 2 |
CACNA1G | 0 | 2 | 0 | 0 | 0 | 2 |
CCDC88C | 0 | 2 | 0 | 0 | 0 | 2 |
DARS2 | 1 | 1 | 0 | 0 | 0 | 2 |
ERCC4 | 2 | 0 | 0 | 0 | 0 | 2 |
GALC | 1 | 1 | 0 | 0 | 0 | 2 |
SYNE1 | 1 | 0 | 0 | 0 | 1 | 2 |
AHDC1 | 0 | 0 | 0 | 0 | 1 | 1 |
AMACR, C1QTNF3-AMACR | 0 | 0 | 1 | 0 | 0 | 1 |
AMPD2 | 1 | 0 | 0 | 0 | 0 | 1 |
APOB | 0 | 0 | 1 | 0 | 0 | 1 |
ARSA | 1 | 0 | 0 | 0 | 0 | 1 |
ATP1A2 | 1 | 0 | 0 | 0 | 0 | 1 |
ATP2B3 | 0 | 1 | 0 | 0 | 0 | 1 |
ATP7B | 1 | 0 | 0 | 0 | 0 | 1 |
C19orf12 | 1 | 0 | 0 | 0 | 0 | 1 |
CACNA1A | 0 | 0 | 1 | 0 | 0 | 1 |
CACNB4 | 0 | 1 | 0 | 0 | 0 | 1 |
CEP290 | 1 | 0 | 0 | 0 | 0 | 1 |
CLN6 | 0 | 1 | 0 | 0 | 0 | 1 |
CYP7B1 | 1 | 0 | 0 | 0 | 0 | 1 |
DAB1 | 0 | 1 | 0 | 0 | 0 | 1 |
DNMT1 | 0 | 1 | 0 | 0 | 0 | 1 |
DNMT1, LOC126862853 | 0 | 1 | 0 | 0 | 0 | 1 |
ELOVL4 | 0 | 1 | 0 | 0 | 0 | 1 |
EXOSC8 | 1 | 0 | 0 | 0 | 0 | 1 |
FA2H | 0 | 1 | 0 | 0 | 0 | 1 |
FAT2 | 0 | 0 | 0 | 1 | 0 | 1 |
GJC2 | 0 | 1 | 0 | 0 | 0 | 1 |
GLB1 | 1 | 0 | 0 | 0 | 0 | 1 |
ITPR1 | 0 | 1 | 0 | 0 | 0 | 1 |
KCNMA1 | 0 | 0 | 1 | 0 | 0 | 1 |
KIF1A | 0 | 1 | 0 | 0 | 0 | 1 |
KIF1C, LOC126862472 | 0 | 1 | 0 | 0 | 0 | 1 |
MKS1 | 0 | 1 | 0 | 0 | 0 | 1 |
MTPAP | 0 | 1 | 0 | 0 | 0 | 1 |
NAGLU | 0 | 0 | 1 | 0 | 0 | 1 |
PEX10 | 1 | 0 | 0 | 0 | 0 | 1 |
PIK3R5 | 0 | 0 | 1 | 0 | 0 | 1 |
PLA2G6 | 1 | 0 | 0 | 0 | 0 | 1 |
POLR3A | 1 | 0 | 0 | 0 | 0 | 1 |
PPT1 | 0 | 1 | 0 | 0 | 0 | 1 |
PUM1 | 0 | 1 | 0 | 0 | 0 | 1 |
SCN2A | 0 | 1 | 0 | 0 | 0 | 1 |
SCN8A | 0 | 0 | 1 | 0 | 0 | 1 |
SEPSECS | 1 | 0 | 0 | 0 | 0 | 1 |
SLC1A3 | 0 | 0 | 0 | 0 | 1 | 1 |
SLC25A46 | 0 | 1 | 0 | 0 | 0 | 1 |
SPAST | 0 | 0 | 1 | 0 | 0 | 1 |
SPG11 | 0 | 0 | 1 | 0 | 0 | 1 |
SPTAN1 | 0 | 1 | 0 | 0 | 0 | 1 |
SYNE2 | 0 | 1 | 0 | 0 | 0 | 1 |
TMEM67 | 0 | 1 | 0 | 0 | 0 | 1 |
TTBK2 | 0 | 0 | 0 | 0 | 1 | 1 |
TUBB3 | 0 | 1 | 0 | 0 | 0 | 1 |
Submitter and significance breakdown #
Submitter | pathogenic | likely pathogenic | uncertain significance | likely benign | benign | total |
---|---|---|---|---|---|---|
Molecular Medicine for Neurodegenerative and Neuromuscular Diseases Unit, IRCCS Fondazione Stella Maris | 33 | 38 | 17 | 1 | 4 | 93 |
Tetreault Lab, University of Montreal Hospital Research Centre (CRCHUM) | 2 | 0 | 0 | 0 | 0 | 2 |
Care4Rare-SOLVE, CHEO | 0 | 0 | 1 | 0 | 0 | 1 |
Institute of Human Genetics, University of Wuerzburg | 0 | 1 | 0 | 0 | 0 | 1 |
Centre for Mendelian Genomics, University Medical Centre Ljubljana | 0 | 0 | 1 | 0 | 0 | 1 |
Molecular Genetics, Royal Melbourne Hospital | 1 | 0 | 0 | 0 | 0 | 1 |